Triple Sulfoid

   
Google
 
Web NewDrugInformation.com

Triple Sulfoid


Drug - Triple Sulfoid
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
Multiple ingredients are in alphabetical order.

Strength - 167MG;167MG;167MG
The potency of the active ingredient(s), Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine). May repeat for multiple part products.

Applicant - PAL PAK
The firm name holding legal responsibility for Triple Sulfoid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 080094
The FDA assigned number to Triple Sulfoid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Triple Sulfoid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Triple Sulfoid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Triple Sulfoid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Triple Sulfoid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pal Pak Inc
The full name of the firm holding legal responsibility for the new application of Triple Sulfoid.

Triple Sulfoid